CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA

LEHI, Utah, June 27, 2023 (GLOBE NEWSWIRE) — CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body’s immune system to fight cancer, today reports that after nearly a year of research, the UCLA team is ready to begin integrating their combined work into a complete vaccine…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *